|
|
|
|
|
|
|
|
|
|
|
|
|
Exhibit 99.2
|
PFIZER INC |
||||||||||||
|
SEGMENT/PRODUCT REVENUES |
||||||||||||
|
SECOND QUARTER 1999 |
||||||||||||
|
(millions of dollars) |
||||||||||||
|
***********QUARTER-TO-DATE************ |
||||||||||||
|
WORLDWIDE |
U.S. |
INTERNATIONAL |
||||||||||
|
1999 |
1998 |
% |
1999 |
1998 |
% |
1999 |
1998 |
% |
||||
|
TOTAL REVENUES |
6,516 |
5,751 |
13 |
3,811 |
3,411 |
12 |
2,705 |
2,340 |
16 |
|||
|
PHARMACEUTICALS |
5,151 |
4,467 |
15 |
3,158 |
2,819 |
12 |
1,993 |
1,648 |
21 |
|||
|
TOTAL HUMAN PHARMACEUTICALS |
4,748 |
4,057 |
17 |
2,981 |
2,646 |
13 |
1,767 |
1,411 |
25 |
|||
|
- CARDIOVASCULAR DISEASES |
2,095 |
1,640 |
28 |
1,202 |
973 |
24 |
893 |
667 |
34 |
|||
|
LIPITOR |
900 |
536 |
68 |
642 |
407 |
57 |
258 |
129 |
101 |
|||
|
NORVASC |
713 |
610 |
17 |
306 |
274 |
12 |
407 |
336 |
21 |
|||
|
CARDURA |
185 |
157 |
18 |
77 |
67 |
14 |
108 |
90 |
22 |
|||
|
ACCUPRIL/ACCURETIC |
127 |
119 |
6 |
61 |
64 |
(4) |
66 |
55 |
18 |
|||
|
PROCARDIA XL |
111 |
154 |
(28) |
111 |
154 |
(28) |
0 |
0 |
--- |
|||
|
- INFECTIOUS DISEASES |
777 |
686 |
13 |
442 |
341 |
29 |
335 |
345 |
(3) |
|||
|
ZITHROMAX |
204 |
161 |
27 |
140 |
95 |
47 |
64 |
66 |
(3) |
|||
|
DIFLUCAN |
225 |
208 |
8 |
99 |
89 |
12 |
126 |
119 |
6 |
|||
|
VIRACEPT |
149 |
126 |
18 |
149 |
106 |
41 |
0 |
20 |
(100) |
|||
|
TROVAN |
35 |
22 |
60 |
24 |
22 |
6 |
11 |
0 |
M+ |
|||
|
- CENTRAL NERVOUS SYSTEM |
743 |
594 |
25 |
578 |
465 |
24 |
165 |
129 |
27 |
|||
|
ZOLOFT |
453 |
390 |
16 |
353 |
305 |
16 |
100 |
85 |
17 |
|||
|
NEURONTIN |
206 |
122 |
69 |
178 |
105 |
71 |
28 |
17 |
63 |
|||
|
ARICEPT* |
22 |
11 |
103 |
0 |
0 |
--- |
22 |
11 |
103 |
|||
|
- DIABETES |
236 |
286 |
(18) |
227 |
277 |
(18) |
9 |
9 |
(2) |
|||
|
GLUCOTROL XL |
56 |
49 |
15 |
54 |
47 |
14 |
2 |
2 |
31 |
|||
|
REZULIN |
171 |
226 |
(24) |
171 |
226 |
(24) |
0 |
0 |
--- |
|||
|
- ALLERGY |
142 |
104 |
37 |
141 |
103 |
37 |
1 |
1 |
(16) |
|||
|
ZYRTEC |
141 |
103 |
38 |
140 |
102 |
38 |
1 |
1 |
(16) |
|||
|
- VIAGRA |
305 |
402 |
(24) |
194 |
401 |
(52) |
111 |
1 |
M+ |
|||
|
- ALLIANCE REVENUE (Aricept |
146 |
16 |
825 |
139 |
17 |
710 |
7 |
(1) |
--- |
|||
|
- CAPSUGEL |
100 |
92 |
9 |
42 |
41 |
4 |
58 |
51 |
12 |
|||
|
- ANIMAL HEALTH |
303 |
318 |
(5) |
135 |
132 |
2 |
168 |
186 |
(10) |
|||
|
CONSUMER PRODUCTS |
1,365 |
1,284 |
6 |
653 |
592 |
10 |
712 |
692 |
3 |
|||
|
- CONSUMER HEALTH CARE |
638 |
571 |
12 |
407 |
354 |
15 |
231 |
217 |
7 |
|||
|
- CONFECTIONERY PRODUCTS |
483 |
468 |
3 |
161 |
155 |
4 |
322 |
313 |
3 |
|||
|
- SHAVING PRODUCTS |
194 |
196 |
(1) |
64 |
63 |
1 |
130 |
133 |
(2) |
|||
|
- TETRA |
50 |
49 |
2 |
21 |
20 |
9 |
29 |
29 |
(2) |
|||
* - Represents direct sales under license agreement with Eisai Co., Ltd.
M+ - Change greater than one thousand percent.
Restated to reflect the merger with Warner-Lambert Company in June 2000, which was accounted for as a pooling of interests.
Certain amounts and percentages may reflect rounding adjustments.
Certain prior year data have been reclassified to conform to the current year presentation.
|
|